US Patent 10314790 | Patents | Expiry | Expiration | Dates

SUPERNUS PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

TOPIRAMATE

Supporting Information : Click here to upload a PDF

US Patent Number

10314790

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-11-16

Patent Use Code

U-1992

Delist Requested

Application Number

201635

Patent Use Description

Product Number

1

SUPERNUS PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

TOPIRAMATE

Supporting Information : Click here to upload a PDF

US Patent Number

10314790

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-11-16

Patent Use Code

U-1675

Delist Requested

Application Number

201635

Patent Use Description

USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY

Product Number

4

SUPERNUS PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

TOPIRAMATE

Supporting Information : Click here to upload a PDF

US Patent Number

10314790

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-11-16

Patent Use Code

U-1675

Delist Requested

Application Number

201635

Patent Use Description

USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY

Product Number

2

SUPERNUS PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

TOPIRAMATE

Supporting Information : Click here to upload a PDF

US Patent Number

10314790

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-11-16

Patent Use Code

U-1992

Delist Requested

Application Number

201635

Patent Use Description

Product Number

4

SUPERNUS PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

TOPIRAMATE

Supporting Information : Click here to upload a PDF

US Patent Number

10314790

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-11-16

Patent Use Code

U-1675

Delist Requested

Application Number

201635

Patent Use Description

USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY

Product Number

3

SUPERNUS PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

TOPIRAMATE

Supporting Information : Click here to upload a PDF

US Patent Number

10314790

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-11-16

Patent Use Code

U-1992

Delist Requested

Application Number

201635

Patent Use Description

Product Number

3

SUPERNUS PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

TOPIRAMATE

Supporting Information : Click here to upload a PDF

US Patent Number

10314790

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-11-16

Patent Use Code

U-1992

Delist Requested

Application Number

201635

Patent Use Description

Product Number

2

SUPERNUS PHARMS

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

TOPIRAMATE

Supporting Information : Click here to upload a PDF

US Patent Number

10314790

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-11-16

Patent Use Code

U-1675

Delist Requested

Application Number

201635

Patent Use Description

USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10314790

Y

2027-11-16

U-1992

1

Y

2027-11-16

U-1675

USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY

4

Y

2027-11-16

U-1675

USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY

2

Y

2027-11-16

U-1992

4

Y

2027-11-16

U-1675

USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY

3

Y

2027-11-16

U-1992

3

Y

2027-11-16

U-1992

2

Y

2027-11-16

U-1675

USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY

1